Declan Noone

1.1k total citations
53 papers, 709 citations indexed

About

Declan Noone is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Declan Noone has authored 53 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Hematology, 6 papers in Genetics and 5 papers in Oncology. Recurrent topics in Declan Noone's work include Hemophilia Treatment and Research (43 papers), Platelet Disorders and Treatments (7 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Declan Noone is often cited by papers focused on Hemophilia Treatment and Research (43 papers), Platelet Disorders and Treatments (7 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Declan Noone collaborates with scholars based in United Kingdom, Ireland and United States. Declan Noone's co-authors include Brian O’Mahony, Lucia Prihodová, Paul Giangrande, Mark W. Skinner, Flora Peyvandi, David Page, Michelle Lavin, Rezan A. Kadir, Karin P. M. van Galen and Randall Curtis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and BMJ.

In The Last Decade

Declan Noone

49 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Declan Noone United Kingdom 16 593 91 71 71 68 53 709
Mark W. Skinner Canada 21 935 1.6× 140 1.5× 197 2.8× 143 2.0× 135 2.0× 59 1.1k
Donna Coffin Canada 10 439 0.7× 70 0.8× 114 1.6× 98 1.4× 80 1.2× 21 599
Roman M. Shapiro United States 14 195 0.3× 48 0.5× 56 0.8× 156 2.2× 31 0.5× 46 497
Emily Farrell Australia 10 169 0.3× 79 0.9× 51 0.7× 80 1.1× 131 1.9× 20 475
Lucilla Lecchi Italy 13 269 0.5× 148 1.6× 75 1.1× 54 0.8× 41 0.6× 36 487
Hernández Spain 7 251 0.4× 89 1.0× 69 1.0× 26 0.4× 26 0.4× 12 316
Julie Vose United States 9 135 0.2× 82 0.9× 34 0.5× 188 2.6× 85 1.3× 18 360
Omar Nadeem United States 13 263 0.4× 58 0.6× 229 3.2× 260 3.7× 20 0.3× 79 468
Lisa Sproat United States 9 155 0.3× 42 0.5× 93 1.3× 82 1.2× 11 0.2× 18 340
Péter Reményi Hungary 13 228 0.4× 135 1.5× 100 1.4× 89 1.3× 19 0.3× 44 400

Countries citing papers authored by Declan Noone

Since Specialization
Citations

This map shows the geographic impact of Declan Noone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Declan Noone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Declan Noone more than expected).

Fields of papers citing papers by Declan Noone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Declan Noone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Declan Noone. The network helps show where Declan Noone may publish in the future.

Co-authorship network of co-authors of Declan Noone

This figure shows the co-authorship network connecting the top 25 collaborators of Declan Noone. A scholar is included among the top collaborators of Declan Noone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Declan Noone. Declan Noone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Curtis, Randall, Joanne Wu, Alfonso Iorio, et al.. (2024). Test–retest reliability of a mobile application of the patient reported outcomes burdens and experiences (PROBE) study. Haemophilia. 30(3). 702–708. 1 indexed citations
4.
Kaczmarek, Radosław, Glenn F. Pierce, Declan Noone, et al.. (2023). Hemophilia gene therapy: first, do no harm. Journal of Thrombosis and Haemostasis. 21(9). 2354–2361. 11 indexed citations
5.
Boban, Ana, Fariba Baghaei, Robert Klamroth, et al.. (2023). Accreditation model of European Haemophilia Centres in the era of novel treatments and gene therapy. Haemophilia. 29(6). 1442–1449. 7 indexed citations
6.
7.
Noone, Declan, et al.. (2022). Key challenges for patient registries – A report from the 1 st workshop of the EHC Think Tank Workstream on Registries. SHILAP Revista de lepidopterología. 9(1). 14–19. 3 indexed citations
8.
Noone, Declan, et al.. (2022). Patient agency: key questions and challenges – A report from the 1st workshop of the EHC Think Tank Workstream on Patient Agency. SHILAP Revista de lepidopterología. 9(1). 27–35. 9 indexed citations
9.
Noone, Declan, et al.. (2022). Key challenges for hub and spoke models of care – A report from the 1st workshop of the EHC Think Tank on Hub and Spoke Treatment Models. SHILAP Revista de lepidopterología. 9(1). 20–26. 9 indexed citations
10.
Postma, Maarten J., Declan Noone, Mark H. Rozenbaum, et al.. (2022). Assessing the value of orphan drugs using conventional cost-effectiveness analysis: Is it fit for purpose?. Orphanet Journal of Rare Diseases. 17(1). 157–157. 22 indexed citations
11.
Kaczmarek, Radosław, Magdy El Ekiaby, Daniel P. Hart, et al.. (2021). Vaccination against COVID‐19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders. Haemophilia. 27(4). 515–518. 6 indexed citations
12.
Stonebraker, Jeffrey S., Brian O’Mahony, Declan Noone, & Alfonso Iorio. (2021). Converting factor and nonfactor usage into a single metric to facilitate benchmarking the resources consumed for haemophilia care across jurisdictions and over time. Haemophilia. 27(5). e596–e608. 4 indexed citations
13.
Johnston, Kate, Brian O’Mahony, Declan Noone, et al.. (2021). Recombinant factor IX‐Fc fusion protein in severe hemophilia B: Patient‐reported outcomes and health‐related quality of life. Research and Practice in Thrombosis and Haemostasis. 5(7). e12602–e12602. 5 indexed citations
14.
Pierce, Glenn F., Radosław Kaczmarek, Declan Noone, et al.. (2020). Gene therapy to cure haemophilia: Is robust scientific inquiry the missing factor?. Haemophilia. 26(6). 931–933. 19 indexed citations
15.
Noone, Declan, Donna Coffin, & Glenn F. Pierce. (2020). Reimbursing the value of gene therapy care in an era of uncertainty. Haemophilia. 27(1). 12–18. 9 indexed citations
16.
Chai‐Adisaksopha, Chatree, Declan Noone, Randall Curtis, et al.. (2020). Non‐severe haemophilia: Is it benign? – Insights from the PROBE study. Haemophilia. 27(S1). 17–24. 25 indexed citations
17.
Chai‐Adisaksopha, Chatree, Mark W. Skinner, Randall Curtis, et al.. (2018). Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire. BMJ Open. 8(8). e021900–e021900. 19 indexed citations
18.
Murphy, Niamh, Brian O’Mahony, Peter Flanagan, et al.. (2017). Progression of hepatitis C in the haemophiliac population in Ireland, after 30 years of infection in the pre‐DAA treatment era. Haemophilia. 23(5). 712–720. 7 indexed citations
19.
Skinner, Mark W., Chatree Chai‐Adisaksopha, Randall Curtis, et al.. (2017). Burden of Comorbid Diseases in Patients with Hemophilia: The Cross-Sectional Analysis of the Patient Reported Outcomes, Burden and Experiences (PROBE) Study. Blood. 130. 3411–3411. 1 indexed citations
20.
Farrugia, Albert, et al.. (2015). Issues in assessing products for the treatment of hemophilia – the intersection between efficacy, economics, and ethics. Journal of Blood Medicine. 6. 185–185. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark W. Skinner Breakdown of academic impact, for papers by Donna Coffin Breakdown of academic impact, for papers by Roman M. Shapiro Breakdown of academic impact, for papers by Emily Farrell Breakdown of academic impact, for papers by Lucilla Lecchi Breakdown of academic impact, for papers by Hernández Breakdown of academic impact, for papers by Julie Vose Breakdown of academic impact, for papers by Omar Nadeem Breakdown of academic impact, for papers by Lisa Sproat Breakdown of academic impact, for papers by Péter Reményi
Rankless by CCL
2026